Activism: latest news

Activism features

Activism in your own words

Activism news from aidsmap

  • European Cure Review concentrates on HIV therapeutic vaccines

    A cure for HIV would almost inevitably have to involve a vaccine to improve the body’s natural ability to control HIV, a seminar on European HIV cure research heard recently. The STEPS seminar, held by the European AIDS Treatment ...

    16 November 2017 | Gus Cairns
  • France’s next PrEP study aims to assess the wider impact of PrEP on the HIV epidemic

    France is launching a new study which will enrol 3000 new pre-exposure prophylaxis (PrEP) users over the next three years, Jean-Michel Molina told the 9th International AIDS Society Conference on HIV Science (IAS 2017) in Paris this week. Whereas previous studies, ...

    28 July 2017 | Roger Pebody
  • Hope overshadowed – the US PrEP Summit

    The US National HIV PrEP Summit, which took place in early December in San Francisco, was one of the most extraordinary HIV meetings I have ever been to. This first-ever gathering of 600 people involved in ...

    31 January 2017 | Gus Cairns
  • Policy makers’ inaction is leading people to take PrEP ‘in the wild’

    An increasing number of gay men and others at risk of HIV are seeking to protect their health with PrEP (pre-exposure prophylaxis), but the lack of PrEP provision and lack of regulatory approval in many countries is leading ...

    19 October 2016 | Roger Pebody
  • Gains in curbing HIV epidemic could be lost without continued commitment, AIDS 2016 speakers say

    Participants at the 21st International AIDS Conference (AIDS 2016), taking place this week in Durban, South Africa, reviewed the remarkable gains that have been made in access to HIV treatment and new prevention tools since the conference was last held ...

    19 July 2016 | Liz Highleyman
  • People who inject drugs have other priorities ahead of PrEP

    People who inject drugs have fundamental concerns about HIV pre-exposure prophylaxis (PrEP) and the manner in which it is being promoted, according to a consultation conducted by the International Network of People who Use Drugs (INPUD). With limited availability ...

    17 June 2016 | Roger Pebody
  • England’s PrEP policy in disarray after NHS U-turn

    Activists, individuals at risk of HIV, and clinicians have reacted with anger to an official U-turn on provision of HIV pre-exposure prophylaxis (PrEP). NHS England officials have refused to allow a draft policy on PrEP to go forward for ...

    22 March 2016 | Roger Pebody
  • London sexual health clinics step up their support for people buying PrEP online

    Several large sexual health clinics in London and Brighton have responded to the growing numbers of people importing PrEP medications from overseas by offering free safety monitoring to PrEP users. This is in a context of increasing frustration with ...

    29 January 2016 | Roger Pebody
  • France approves PrEP

    In a historic move, France has become the first country outside the USA, and the first country with a centrally-organised, reimbursable health system, to approve no-expense pre-exposure prophylaxis (PrEP) for people who need it.The French Minister of Health, ...

    24 November 2015 | Gus Cairns
  • Harm reduction conference calls for political leadership to reform drugs policy

    The biggest challenges to harm reduction are drugs policy and drugs laws, the Malaysian harm reduction leader Dr Adeeba Kamarulzaman told the 24th International Harm Reduction Conference in Kuala Lumpur last week.Numerous speakers said that punitive and prohibitionist drugs policies have restricted ...

    27 October 2015 | Roger Pebody
More news

Activism news selected from other sources

  • David Cooper: Champion of the people

    In March, Australia and the world lost one of the leading figures in the fight against HIV/AIDS. Christopher Kelly pays tribute to Professor David Cooper.

    15 June 2018 | Positive Living
  • How to Deal With Conflicts About Ex-Lovers, HIV, Trump and More

    A provocative interview with author Sarah Schulman also reveals the most pressing issues facing gay people and the HIV community.

    13 June 2018 | Poz
  • In the face of a misguided response to HIV/AIDS in Russia, these bright stars are taking charge

    In 2015, Pavel Lobkov, a news anchor on TV Rain, an independent station in Moscow, confronted a predicament unlike any he had faced in more than 2 decades working as a journalist. It was World AIDS Day, and he was slated to host a show. His guest was the head of the Federal Center for the Prevention and Control of the Spread of AIDS, Vadim Pokrovsky. For 12 years, Lobkov had been Pokrovsky’s patient.

    12 June 2018 | Science
  • UNAIDS - Past Time to Get Serious

    "UNAIDS still has much work to do. It is not doing that work because it is paralyzed by crisis. If UNAIDS doesn't change, it will have no future."

    11 June 2018 | Hunavat Global
  • Our CEO Monty Moncrieff is awarded an MBE

    London Friend’s Chief Executive, Monty Moncrieff, has been awarded an MBE in the Queen’s Birthday Honours. The award, for services to LGBT equality, recognises work done by London Friend to improve the health and wellbeing of LGBT people.

    11 June 2018 | London Friend
  • How Are Early Members of ACT UP Adjusting Today?

    A new study assesses the long-term impact of AIDS activism, including trauma, loss, posttraumatic growth and a belief in change.

    05 June 2018 | Poz
  • 500 Days and Trump Administration Absent on HIV

    It has been 500 days since Donald Trump became President of the United States. And it has been 500 days since The White House had any substantial leadership working on behalf of the HIV epidemic or talking prevention strategies. And the blame for that must be shared by us all.

    01 June 2018 | I'm Still Josh
  • Industry Interview: Tom Viola and the Evolution of Broadway Cares/Equity Fights AIDS

    For the past thirty years, Broadway Cares/Equity Fights AIDS has been a vital part of the theatre community, and Tom Viola, the organization's executive director since 1996, has been around to nurture its growth since the organization's inception in 1988.

    29 May 2018 | Broadway World
  • Collective Efforts By Civil Society Groups Bar The Way To Hepatitis C Patents

    Many hold the view that Gilead’s revolutionary treatment against hepatitis C (sofosbuvir) marked the beginning of a shift in position toward the high prices of medicines, as high-income countries were also faced with an untenable burden to their health systems. In a number of lower and middle-income countries civil society organised itself to increase access to sofosbuvir for millions in need.

    14 May 2018 | Intellectual Property Watch
  • Transition Notice: Dr Laurel Sprague leaves GNP+

    It is with sadness and gratitude that the Board of the Global Network of People Living with HIV (GNP+) announces Dr. Laurel Sprague’s departure as Executive Director, effective 18 May 2018.

    24 April 2018 | Global Network of People Living with HIV and AIDS (GNP+)
More news
Tell us why you visited aidsmap today
minimise

Could you help us by answering three questions on why you’ve visited aidsmap today?

You can close this questionnaire and come back to it later. Just click on the pink circle.

What prompted you to visit aidsmap today?

What exactly are you looking for? What specific questions do you need answered?

Have you found what you were looking for?

close

Thank you for your feedback

Thank you very much for taking time to fill in this questionnaire. NAM really values your feedback. It helps make the information we provide better.

If you have any other comments on the content of this website, we would be interested to hear from you. Please email info@nam.org.uk.

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.